MP-412

N/A

Report date: 2026/05/12 20:00:17
NME

Base Information

Drug NameMP-412
Drug Alias NameAV-412MP-412
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEGFR T790M inhibitorsEGFR L858R inhibitorsEpidermal growth factor receptor erbB1 inhibitors +[4] 
TargetsEpidermal growth factor receptor erbB1Receptor protein-tyrosine kinase erbB-2EGFR T790M +[4] 
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesArgentina
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMitsubishi Tanabe Pharma
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAveo Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksWikipedia